1) Biliary Obstruction
胆系梗阻
2) biliary obstruction
胆道梗阻
1.
Endoscopic metal stents drainage in treatment of malignant biliary obstruction;
经内镜胆道金属支架引流术治疗恶性胆道梗阻的价值
2.
Evaluation of MR cholangiopancreatography combined with magnetic resonance imaging in diagnosis of biliary obstruction;
磁共振胆胰管成像联合磁共振成像诊断胆道梗阻的价值
3.
Experimental study on myocardial injury and the protective effects of tetramethylpyrazine after biliary obstruction;
胆道梗阻后心肌损伤及川芎嗪保护作用的实验研究
3) bile duct obstruction
胆管梗阻
1.
ERBD in management of benign and malignant bile duct obstruction;
胆管内支架引流治疗良恶性胆管梗阻32例分析
2.
Evaluation of MRCP using single shot projection and thick slice technique in diagnosis of extrahepatic bile duct obstruction disease;
SSFSE-MRCP对肝外胆管梗阻性疾病的诊断价值
4) biliary obstruction
胆管梗阻
1.
Objective To evaluate the clinical effect and value of stents for treatment of malignant biliary obstruction.
方法对279例恶性胆管梗阻(高位梗阻127例,中低位梗阻152例)分别采用单点位单支架及双点位双通道双支架置入,单点位单通道双支架置入或单支架置入配合外引流的治疗方法。
2.
Objective To study the interventional procedure for malignant biliary obstruction.
结果 中下段胆管梗阻疗效好 ,治疗一周后多数患者血清胆红素下降超过 5 0 % ,15天后有 16例患者血清胆红素降至正常。
3.
Objective The aim of this study was to evaluate magnetic resonance cholangiopancreatography(MRCP)using half-Fourier acquisition single-shot fast spin-echo(HASTE)sequence in the diagnosis of biliary obstructions.
目的 探讨采用半傅立叶单次激发快速自旋回波序列 (HASTE)的磁共振胰胆管成像 (MRCP)对胆管梗阻性疾病的诊断价值。
5) bile duct obstruction
胆道梗阻
1.
Clinical research of percutaneous transhepatic biliary stent placement for malignant bile duct obstruction
经皮肝穿胆道支架置入治疗恶性胆道梗阻的临床研究
2.
Methods Wistar rats were divided randomly into N PH group in which 70% partial hepatectomy were operated, BDO PH group in which 70% partial hepatectomy were operated after restoration of bile flow (RBF) following 1 week s bile duct obstruction and BDO RBF group in which only RBF were operated after BDO.
目的 检测胆道梗阻肝脏部分切除术 (PH)后肝细胞周期素 (cyclin)D1 、E及细胞周期素依赖性激酶CDK2、CDK4mRNA的表达变化。
3.
Objective To explore the effects of Kupffer cells(KCs) NF κB activation on liver regeneration after 70% partial hepatectomy(PH) in rats with noncirrhotic bile duct obstruction(BDO).
目的 探讨Kupffer细胞 (KCs)NF κB激活在鼠非肝硬变性胆道梗阻肝部分切除后肝细胞再生过程中的作用。
补充资料:舒胆通,胆灵
药物名称:曲匹布通
英文名:Trepibutone
别名: 舒胆通,胆灵;三乙氧苯酰丙酸 ,曲匹布通,三乙丁酮
外文名:Trepibutone
适应症: 主要用于胆石症、胆囊炎、胆道运动障碍、胆囊术后综合征及慢性胰腺炎等。
用量用法: 口服:每次1片,1日3次,饭后服用。1个疗程为2~4周。
注意事项:
本品不良反应轻微,对中枢神经系统、心血管系统、消化系统及肾功能等几乎无不良影响。孕妇禁用,完全性胆道梗阻及急性胰腺炎病人慎用。
规格: 片剂:每片40mg。
类别:肝胆疾病药及辅助用药
英文名:Trepibutone
别名: 舒胆通,胆灵;三乙氧苯酰丙酸 ,曲匹布通,三乙丁酮
外文名:Trepibutone
适应症: 主要用于胆石症、胆囊炎、胆道运动障碍、胆囊术后综合征及慢性胰腺炎等。
用量用法: 口服:每次1片,1日3次,饭后服用。1个疗程为2~4周。
注意事项:
本品不良反应轻微,对中枢神经系统、心血管系统、消化系统及肾功能等几乎无不良影响。孕妇禁用,完全性胆道梗阻及急性胰腺炎病人慎用。
规格: 片剂:每片40mg。
类别:肝胆疾病药及辅助用药
说明:补充资料仅用于学习参考,请勿用于其它任何用途。
参考词条